Wakefulness-promoting agent

#	Item
1	PROVIGIL® (modafinil) Tablets [C-IV] Add to Reading List Source URL: www.biopsychiatry.com Language: English - Date: 2009-03-02 13:30:00 Pharmacology Nootropics Biology Sulfoxides Attention-deficit hyperactivity disorder Modafinil Narcolepsy Excessive daytime sleepiness Wakefulness-promoting agent Stimulants Medicine Sleep disorders
2	FDA Approved Labeling Text for NDA[removed]NUVIGIL™ (armodafinil) Tablets Approved Labeling dated June 15, 2007 Add to Reading List Source URL: corpina.org Language: English - Date: 2014-03-09 13:24:09 Nootropics Acetamides Chemistry Neurology Sulfoxides Modafinil Armodafinil Narcolepsy Wakefulness-promoting agent Stimulants Sleep disorders Medicine
3	PI + MG October[removed]NUVIGIL® (armodafinil) Tablets [C-IV] Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-10-25 17:29:48 Biology Nootropics Acetamides Chemistry Sleep Modafinil Armodafinil Narcolepsy Wakefulness-promoting agent Sleep disorders Medicine Stimulants
4	PROVIGIL® (modafinil) Tablets [C-IV] Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-11-23 08:41:12 Pharmacology Nootropics Biology Sulfoxides Attention-deficit hyperactivity disorder Modafinil Narcolepsy Excessive daytime sleepiness Wakefulness-promoting agent Stimulants Medicine Sleep disorders